[Analysis of Risk Factors of Herpes Zoster in Patients with Multiple Myeloma Treated with Bortezomib].

MLA

Li, Gao, et al. “[Analysis of Risk Factors of Herpes Zoster in Patients with Multiple Myeloma Treated with Bortezomib].” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 28, no. 6, Dec. 2020, pp. 1972–76. EBSCOhost, https://doi.org/10.19746/j.cnki.issn.1009-2137.2020.06.029.

APA

Li, G., Zhang, Q.-K., Wei, X.-F., Feng, Y.-F., Yang, W.-H., & Sun, Y.-Q. (2020). [Analysis of Risk Factors of Herpes Zoster in Patients with Multiple Myeloma Treated with Bortezomib]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 28(6), 1972–1976. https://doi.org/10.19746/j.cnki.issn.1009-2137.2020.06.029

Chicago

Li, Gao, Qi-Ke Zhang, Xiao-Fang Wei, You-Fan Feng, Wen-Hui Yang, and Yan-Qing Sun. 2020. “[Analysis of Risk Factors of Herpes Zoster in Patients with Multiple Myeloma Treated with Bortezomib].” Zhongguo Shi Yan Xue Ye Xue Za Zhi 28 (6): 1972–76. doi:10.19746/j.cnki.issn.1009-2137.2020.06.029.